TES-1025 |
TES-1025 : Inhibitor of ACMSD
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| ACMSD |
|
|
Inhibitor
5 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Activity on a panel of nuclear receptors: PXR, PPARs, LXR, VDR, GR, RXR, FXR, TR, was based on Alpha ...
Potency Cellular
In Vitro
ACMSD
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.7b01254
In Vivo Validations
Mouse
Dose: 0.5 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
5.33 h
Systemic clearance:
0.78 mL/min/kg
Area Under the Curve::
10700 h·ng/mL
Volume of Distribution at Steady-State:
0.273 L/Kg
DOI Reference: 10.1021/acs.jmedchem.7b01254
Dose: 5 mg/Kg
Route of delivery:
Oral
Cmax:
2570 ng/mL
Tmax:
2.0 h
Area Under the Curve::
12700 (heart), 19200 (liver), 36600 (kidney) h·ng/mL
Bioavailability:
12%
DOI Reference: 10.1021/acs.jmedchem.7b01254
Chemical Information
| Molecular Formula | C17H12N4O3S2 |
| SMILEs | N#Cc1c(-c2cccs2)nc(SCc2cccc(C(=O)NO)c2)[nH]c1=O |
| InChI | InChI=1S/C17H12N4O3S2/c18-8-12-14(13-5-2-6-25-13)19-17(20-16(12)23)26-9-10-3-1-4-11(7-10)15(22)21-24/h1-7,24H,9H2,(H,21,22)(H,19,20,23) |
| Molecular weight | 384.04 Da |
| AlogP | 2.7813800000000004 |
| HBond acceptors | 7 |
| HBond donors | 3 |
| Atoms | 38 |
| PAINS * | Yes |
* This is an automated alert only, and may not necessarily indicate an issue with this probe. ( Learn more about PAINS )
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.